These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 869055)

  • 1. Electrophysiological (H-reflex) studies of patients with tardive dyskinesia.
    Crayton JW; Smith RC; Klass D; Chang S; Ericksen SE
    Am J Psychiatry; 1977 Jul; 134(7):775-81. PubMed ID: 869055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of dopamine agonists in tardive dyskinesia.
    Smith RC; Tamminga CA; Haraszti J; Pandey GN; Davis JM
    Am J Psychiatry; 1977 Jul; 134(7):763-8. PubMed ID: 869053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholinergic influences in tardive dyskinesia.
    Tamminga CA; Smith RC; Ericksen SE; Chang S; Davis JM
    Am J Psychiatry; 1977 Jul; 134(7):769-74. PubMed ID: 869054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paradoxical response to dopamine agonists in tardive dyskinesia.
    Carroll BJ; Curtis GC; Kokmen E
    Am J Psychiatry; 1977 Jul; 134(7):785-9. PubMed ID: 17308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Electrophysiological and pharmacological analysis of L-dopa-induced dyskinesia and tardive dyskinesia (author's transl)].
    Bathien N; Rondot P; Koutlidis RM
    J Physiol (Paris); 1981 Apr; 77(1):131-41. PubMed ID: 6112268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bereitschaftspotential in tardive dyskinesia.
    Adler LE; Pecevich M; Nagamoto H
    Mov Disord; 1989; 4(2):105-12. PubMed ID: 2733704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A neuroendocrine study of supersensitivity in tardive dyskinesia.
    Tamminga CA; Smith RC; Pandey G; Frohman LA; Davis JM
    Arch Gen Psychiatry; 1977 Oct; 34(10):1199-203. PubMed ID: 911219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Midification of tardive dyskinesia and spasmodic torticollis by apomorphine. Possible role of dopamine autoreceptors.
    Tolosa ES
    Arch Neurol; 1978 Jul; 35(7):459-62. PubMed ID: 666598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a subgroup of tardive dyskinesia patients by pharmacologic probes.
    Moore DC; Bowers MB
    Am J Psychiatry; 1980 Oct; 137(10):1202-5. PubMed ID: 6106390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pathophysiology of tardive dyskinesia.
    Klawans HL; Carvey P; Tanner CM; Goetz CG
    J Clin Psychiatry; 1985 Apr; 46(4 Pt 2):38-41. PubMed ID: 2858479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MK-771 antagonizes the enhanced response to apomorphine in rats treated chronically with haloperidol - implications for tardive dyskinesia.
    Yarbrough GG; Faison EP; Antolik EK
    Neurosci Lett; 1982 Dec; 34(3):321-3. PubMed ID: 6819493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apomorphine and schizophrenia. Treatment, CSF, and neuroendocrine responses.
    Levy MI; Davis BM; Mohs RC; Kendler KS; Mathé AA; Trigos G; Horvath TB; Davis KL
    Arch Gen Psychiatry; 1984 May; 41(5):520-4. PubMed ID: 6372737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacologic characteristics of Meige dystonia: differentiation from tardive dyskinesia.
    Stahl SM; Yesavage JA; Berger PA
    J Clin Psychiatry; 1982 Nov; 43(11):445-6. PubMed ID: 7174619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dimethylaminoethanol (deanol): effect on apomorphine-induced stereotypy and an animal model of tardive dyskinesia.
    Davis KL; Hollister LE; Vento AL; Beilstein BA; Rosekind GR
    Psychopharmacology (Berl); 1979 May; 63(2):143-6. PubMed ID: 112632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Similar effect of estradiol and haloperidol on experimental tardive dyskinesia in monkeys.
    Bédard PJ; Boucher R; Daigle M; Di Paolo T
    Psychoneuroendocrinology; 1984; 9(4):375-9. PubMed ID: 6514933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ECT and tardive dyskinesia.
    Lerer B
    J Clin Psychiatry; 1984 Apr; 45(4):188. PubMed ID: 6715296
    [No Abstract]   [Full Text] [Related]  

  • 17. Postsynaptic supersensitivity in schizophrenia.
    Pandey GN; Garver DL; Tamminga C; Ericksen S; Ali SI; Davis JM
    Am J Psychiatry; 1977 May; 134(5):518-22. PubMed ID: 848578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disappearance of tardive dyskinesia during catatonic stupor.
    Assmann VC; van Woerkom TC
    Acta Psychiatr Scand; 1987 Aug; 76(2):217-8. PubMed ID: 3673646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tardive dyskinesia: a clinical test of the supersensitivity hypothesis.
    Bowers MB; Moore D; Tarsy D
    Psychopharmacology (Berl); 1979 Mar; 61(2):137-41. PubMed ID: 220654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroendocrine effects of apomorphine in chronic schizophrenic patients under long-term neuroleptic therapy and after drug withdrawal: relations to psychopathology and tardive dyskinesia.
    Müller-Spahn F; Ackenheil M; Albus M; May G; Naber D; Welter D; Zander K
    Psychopharmacology (Berl); 1984; 84(3):436-40. PubMed ID: 6151210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.